Literature DB >> 24421785

Outpatient parenteral antimicrobial therapy.

Kevin B Laupland1, Louis Valiquette2.   

Abstract

Entities:  

Year:  2013        PMID： 24421785      PMCID： PMC3630020          DOI： 10.1155/2013/205910

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  39 in total

Review 1.  Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.

Authors:  Ann L N Chapman; R Andrew Seaton; Mike A Cooper; Sara Hedderwick; Vicky Goodall; Corienne Reed; Frances Sanderson; Dilip Nathwani
Journal:  J Antimicrob Chemother       Date:  2012-01-31       Impact factor: 5.790

2.  Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey.

Authors:  Aarthi Chary; Alan D Tice; Lawrence P Martinelli; Laura A Liedtke; Melissa S Plantenga; Larry J Strausbaugh
Journal:  Clin Infect Dis       Date:  2006-10-10       Impact factor: 9.079

3.  Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group.

Authors:  K B Laupland; H D Davies
Journal:  Clin Invest Med       Date:  2001-08       Impact factor: 0.825

4.  Outpatient intravenous medications in the management of cystic fibrosis.

Authors:  R W Rucker; G M Harrison
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

5.  Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.

Authors:  Rohit Bazaz; Ann L N Chapman; Trevor G Winstanley
Journal:  J Antimicrob Chemother       Date:  2010-05-11       Impact factor: 5.790

6.  Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study.

Authors:  D A Barr; L Semple; R A Seaton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-12       Impact factor: 3.267

7.  Standardized outpatient management of Klebsiella pneumoniae liver abscesses.

Authors:  Douglas S G Chan; Sophia Archuleta; Ryan M Llorin; David C Lye; Dale Fisher
Journal:  Int J Infect Dis       Date:  2012-11-13       Impact factor: 3.623

8.  Outpatient intravenous treatment for infective endocarditis: safety, effectiveness and one-year outcomes.

Authors:  Matthew R Amodeo; Tamlin Clulow; John Lainchbury; David R Murdoch; Kate Gallagher; Amanda Dyer; Sarah L Metcalf; Alan D Pithie; Stephen T Chambers
Journal:  J Infect       Date:  2009-09-17       Impact factor: 6.072

9.  Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.

Authors:  Philippa C Matthews; Christopher P Conlon; Anthony R Berendt; Jill Kayley; Lorrayne Jefferies; Bridget L Atkins; Ivor Byren
Journal:  J Antimicrob Chemother       Date:  2007-06-11       Impact factor: 5.790

10.  Intravenous antibiotic therapy at home.

Authors:  H G Stiver; G O Telford; J M Mossey; D D Cote; E J van Middlesworth; S K Trosky; N L McKay; W L Mossey
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391
View more
  9 in total

1.  Potential savings through single-dose intravenous Dalbavancin in long-term MRSA infection treatment - a health economic analysis using German DRG data.

Authors:  Michael Wilke; Kerstin Worf; Birgit Preisendörfer; Wolfgang Heinlein; Tilman Kast; Klaus-Friedrich Bodmann
Journal:  GMS Infect Dis       Date:  2019-10-23

2.  Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting.

Authors:  Catherine G Derington; Nancy Benavides; Thomas Delate; Douglas N Fish
Journal:  Open Forum Infect Dis       Date:  2020-01-29       Impact factor: 3.835

Review 3.  Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization.

Authors:  Oriana Simonetti; Giulio Rizzetto; Elisa Molinelli; Oscar Cirioni; Annamaria Offidani
Journal:  Ther Clin Risk Manag       Date:  2021-03-22       Impact factor: 2.423

4.  Evaluate the Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) Program in Saudi Arabia: A Retrospective Study.

Authors:  Haneen J Al Shareef; Adnan Al Harbi; Yasser Alatawi; Ahmed Aljabri; Mohammed A Al-Ghanmi; Mohammed S Alzahrani; Majed Ahmed Algarni; Attiah Khobrani; Abdul Haseeb; Faisal AlSenani; Mahmoud E Elrggal
Journal:  Antibiotics (Basel)       Date:  2022-03-24

5.  Outpatient parenteral antimicrobial therapy for orthopedic infections - a successful public healthcare experience in Brazil.

Authors:  Priscila Rosalba Oliveira; Cassia da Silva Felix; Vladimir Cordeiro de Carvalho; Arlete Mazzini Giovani; Rosangela Suarti Dos Reis; Marisa Beraldo; Edmir Peralta Albuquerque; Walter Cintra Ferreira; Jorge Dos Santos Silva; Ana Lucia Lei Lima
Journal:  Braz J Infect Dis       Date:  2016-04-18       Impact factor: 3.257

6.  The cellulitis season is open.

Authors:  Louis Valiquette; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-07       Impact factor: 2.471

7.  Chemical Stability of Ceftolozane/Tazobactam in Polyvinylchloride Bags and Elastomeric Pumps.

Authors:  Joseph Terracciano; Elizabeth G Rhee; Jacqueline Walsh
Journal:  Curr Ther Res Clin Exp       Date:  2017-03-06

8.  Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study.

Authors:  Victoria Huang; Jorg J Ruhe; Polina Lerner; Marianna Fedorenko
Journal:  BMC Pharmacol Toxicol       Date:  2018-08-06       Impact factor: 2.483

Review 9.  The Continuing Threat of Methicillin-Resistant Staphylococcus aureus.

Authors:  Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2019-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.